These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35462848)

  • 1. Identification of a Four-Gene Metabolic Signature to Evaluate the Prognosis of Colon Adenocarcinoma Patients.
    Zheng Y; Wu R; Wang X; Yin C
    Front Public Health; 2022; 10():860381. PubMed ID: 35462848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
    Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
    [No Abstract]   [Full Text] [Related]  

  • 3. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
    Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose metabolism-based signature predicts prognosis and immunotherapy strategies for colon adenocarcinoma.
    Bai Z; Yan C; Nie Y; Zeng Q; Xu L; Wang S; Chang D
    J Gene Med; 2024 Jan; 26(1):e3620. PubMed ID: 37973153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
    Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INHBA is a prognostic predictor for patients with colon adenocarcinoma.
    Li X; Yu W; Liang C; Xu Y; Zhang M; Ding X; Cai X
    BMC Cancer; 2020 Apr; 20(1):305. PubMed ID: 32293338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism-related lncRNAs signature to predict the prognosis of colon adenocarcinoma.
    Sun Y; Liu B; Xiao B; Jiang X; Xiang JJ; Xie J; Hu XM
    Cancer Med; 2023 Mar; 12(5):5994-6008. PubMed ID: 36366731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma.
    Wang H; Wang W; Wang Z; Li X
    Front Immunol; 2023; 14():1291859. PubMed ID: 38143740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma.
    Yang M; He H; Peng T; Lu Y; Yu J
    Comput Intell Neurosci; 2022; 2022():8598046. PubMed ID: 35392038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of sixteen metabolic genes as potential biomarkers for colon adenocarcinoma.
    Zhao F; Liu Y; Gu X; Zhang B; Song C; Cui B
    J BUON; 2021; 26(4):1252-1259. PubMed ID: 34564978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma.
    Yi K; Wu J; Tang X; Zhang Q; Wang B; Wang F
    Scand J Gastroenterol; 2022 Feb; 57(2):214-221. PubMed ID: 34644216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
    Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
    Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma.
    Miao YD; Kou ZY; Wang JT; Mi DH
    World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a RiskScore Model based on Angiogenesis-related lncRNAs for Colon Adenocarcinoma Prognostic Prediction.
    Li X; Lei J; Shi Y; Peng Z; Gong M; Shu X
    Curr Med Chem; 2024; 31(17):2449-2466. PubMed ID: 37961859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of Gene Expression Profiles Identifies a
    Chen Z; Chen M; Xue Z; Zhu X
    Cancer Biother Radiopharm; 2021 Oct; 36(8):693-704. PubMed ID: 34520234
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification prognosis-associated immune genes in colon adenocarcinoma.
    Miao Y; Wang J; Ma X; Yang Y; Mi D
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.
    Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J
    Front Immunol; 2022; 13():881359. PubMed ID: 35911752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of a Prognostic Model based on 11 E3-related Genes for Colon Cancer Patients.
    JIang W; Dong J; Zhang W; Huang Z; Guo T; Zhang K; Jiang X; Du T
    Curr Pharm Des; 2024; 30(12):935-951. PubMed ID: 38898815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a prognostic model for personalized prediction of colon adenocarcinoma (COAD) patient outcomes using methylation-driven genes.
    Chen D; Zhang B; Kang K; Li L; Liao Y; Qing S; Di Y
    J Appl Genet; 2023 Dec; 64(4):713-721. PubMed ID: 37589877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
    Xu M; Mu J; Wang J; Zhou Q; Wang J
    Front Oncol; 2022; 12():961213. PubMed ID: 35965536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.